info@labassure.com
9999746045
Download Reports
Partner Login
Facebook
Google-plus-g
Twitter
Linkedin-in
Pinterest-p
info@labassure.com
9999746045
Facebook
Google-plus-g
Twitter
Linkedin-in
Pinterest-p
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Menu
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Menu
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Menu
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Download Reports
Partner Login
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Menu
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Download Reports
Partner Login
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Menu
Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Testing (NIPT)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Research
Training
Blog
Book A Test
Login
Download Reports
Partner Login
Download Reports
Partner Login
Infectious Disorders
Home
infectious disorders
Infectious Disorders
Leverage the Power Molecular Technologies for Faster and More Accurate and Actionable Diagnosis in Case of Infectious Disorders
Advantages of Molecular Testing for Viral Infections
Rapid antigen tests are not always sensitive
Clinical presentation for several infections are at times, not specific
Easier sample transportation for molecular assays as compared to culture samples
Sensitivity of molecular assays estimated to be 3 to 5 times that of culture-based assays
Molecular tests identify approximately 50% more viral pathogens than culture
*Source: CAP Today, CDC 2011, Cochrane Review 2010
List of Pathogens
BK Virus (BKV)
Cytomegalovirus (CMV)
Chlamydia Trachomatis
COVID 19 - SARS-COV-2
Chikungunya
Dengue
Epstein-Barr virus (EBV)
Herpes Simplex Virus (HSV)
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
H1N1, H3N2
Influenza Type A and Type B
Leptospirosis
Mycobacterium Tuberculosis (MTB)
MTB PCR for Tissue Sample
NTM/MTB (MOTT)
MTB MDR Drug Resistance
Neisseria Gonorrhoeae
Pan Fungal
Parvovirus B19
Respiratory syncytial Virus (RSV)
Rubella PCR
Toxoplasma
TORCH PCR
Varicella Zoster Virus (VZV)
Zika Virus
Introducing Universal Pathogen Detection Solution Soon
Advanced Genomics Institute and Laboratory Medicine
www.labassure.com
I
+ 91 9999746045